Eli Lilly and Company will buy Monsanto’s Posilac division for US$300 million, the companies announced Aug. 20. Monsanto put its bovine somatotropin business up for sale a few weeks ago, saying it wanted to focus more on its core strengths selling high-tech seeds and weed control to farmers. Elanco, headquartered in Greenfield Indiana, is the […] Read more
